Medical Grade Cbd Gummies: A Comprehensive Guide To Purity, Safety, And Clinical …
✦ New CED Clinical Relevance #77 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. CBDSafetyHempResearchDosingIndustryMental Health Clinical Summary This article reviews medical-grade CBD gummy…
7/10: What to Know About National Dab Day
✦ New CED Clinical Relevance #47 Clinical Context Background information relevant to the evolving cannabis medicine landscape. THCResearchSafetyDosingIndustryHempCBD Why This Matters Clinicians should understand that cannabis concentrates like…
Resomelagon shows reduced inflammation and joint damage in osteoarthritis model
✦ New CED Clinical Relevance #47 Clinical Context Background information relevant to the evolving cannabis medicine landscape. ResearchPainAgingCBDSafetyIndustryNeurology Clinical Summary A novel cannabinoid-based compound called resomelagon…
Why Did Ananda Developments Bounce On Its Latest Acquisition News?
✦ New CED Clinical Relevance #62 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. CBDTHCResearchIndustryPolicyHempSafety Clinical Summary Ananda Developments' acquisition of a cannabis medicine…
Curaleaf International launches CPD-accredited medical cannabis education platform
Curaleaf International has launched a CPD-accredited medical cannabis education platform to support clinicians. This platform provides structured learning pathways to improve cannabis clinical knowledge. It addresses the critical need for accredited…
DEA’s Own Pharmacologist Undercuts Marijuana Rescheduling Order
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicyResearchNeurologyMental HealthSafetyIndustryPain Why This Matters A DEA pharmacologist's testimony suggesting…
Can You Actually Buy a Safe Cannabis Vape Pen?
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. CBDTHCHempSafetyIndustryDosingResearch Clinical Summary # Clinical Summary This article examines the safety and quality…
Wyoming Rejects Trump Administration’s Schedule III Cannabis Listing; Keeps It Schedule I
✦ New CED Clinical Relevance #35 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyHempCBDTHCResearchSafetyIndustry Why This Matters Wyoming's rejection of federal Schedule III…
No longer able to purchase out-of-state, Ky medical cannabis patients suffer sticker shock
✦ New CED Clinical Relevance #35 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PainPolicyIndustrySafetyAnxietyMental HealthDosing Why This Matters Kentucky's elimination of out-of-state cannabis…
Cheap, High-THC Products Are Driving Germany’s Medical Cannabis Market
✦ New CED Clinical Relevance #35 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyResearchTHCIndustryPainMental HealthSafety Why This Matters Clinicians in Germany and similar regulated markets…